» Articles » PMID: 33968128

The Molecular Functions of MeCP2 in Rett Syndrome Pathology

Overview
Journal Front Genet
Date 2021 May 10
PMID 33968128
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

MeCP2 protein, encoded by the gene, binds to DNA and affects transcription. Outside of this activity the true range of MeCP2 function is still not entirely clear. As gene mutations cause the neurodevelopmental disorder Rett syndrome in 1 in 10,000 female births, much of what is known about the biologic function of MeCP2 comes from studying human cell culture models and rodent models with gene mutations. In this review, the full scope of MeCP2 research available in the NIH Pubmed (https://pubmed.ncbi.nlm.nih.gov/) data base to date is considered. While not all original research can be mentioned due to space limitations, the main aspects of MeCP2 and Rett syndrome research are discussed while highlighting the work of individual researchers and research groups. First, the primary functions of MeCP2 relevant to Rett syndrome are summarized and explored. Second, the conflicting evidence and controversies surrounding emerging aspects of MeCP2 biology are examined. Next, the most obvious gaps in MeCP2 research studies are noted. Finally, the most recent discoveries in MeCP2 and Rett syndrome research are explored with a focus on the potential and pitfalls of novel treatments and therapies.

Citing Articles

Decoding TDP-43: the molecular chameleon of neurodegenerative diseases.

Zeng J, Luo C, Jiang Y, Hu T, Lin B, Xie Y Acta Neuropathol Commun. 2024; 12(1):205.

PMID: 39736783 PMC: 11687198. DOI: 10.1186/s40478-024-01914-9.


ALG13-Related Epilepsy: Current Insights and Future Research Directions.

Gao P, Chen H, Sun Y, Qian X, Sun T, Fan Y Neurochem Res. 2024; 50(1):60.

PMID: 39673593 DOI: 10.1007/s11064-024-04300-y.


The epigenetic modification of DNA methylation in neurological diseases.

Li L, Chen R, Zhang H, Li J, Huang H, Weng J Front Immunol. 2024; 15:1401962.

PMID: 39376563 PMC: 11456496. DOI: 10.3389/fimmu.2024.1401962.


Drug repurposing in Rett and Rett-like syndromes: a promising yet underrated opportunity?.

Fuchs C, t Hoen P, Muller A, Ehrhart F, van Karnebeek C Front Med (Lausanne). 2024; 11:1425038.

PMID: 39135718 PMC: 11317438. DOI: 10.3389/fmed.2024.1425038.


Irradiation and Alterations in Hippocampal DNA Methylation.

Impey S, Raber J Epigenomes. 2024; 8(3).

PMID: 39051185 PMC: 11270359. DOI: 10.3390/epigenomes8030027.


References
1.
McMahon A, Rahman R, Jin H, Shen J, Fieldsend A, Luo W . TRIBE: Hijacking an RNA-Editing Enzyme to Identify Cell-Specific Targets of RNA-Binding Proteins. Cell. 2016; 165(3):742-53. PMC: 5027142. DOI: 10.1016/j.cell.2016.03.007. View

2.
Valinluck V, Liu P, Kang Jr J, Burdzy A, Sowers L . 5-halogenated pyrimidine lesions within a CpG sequence context mimic 5-methylcytosine by enhancing the binding of the methyl-CpG-binding domain of methyl-CpG-binding protein 2 (MeCP2). Nucleic Acids Res. 2005; 33(9):3057-64. PMC: 1140371. DOI: 10.1093/nar/gki612. View

3.
Zoghbi H . MeCP2 dysfunction in humans and mice. J Child Neurol. 2005; 20(9):736-40. DOI: 10.1177/08830738050200090701. View

4.
Millar-Buchner P, Philp A, Gutierrez N, Villanueva S, Kerr B, Flores C . Severe changes in colon epithelium in the Mecp2-null mouse model of Rett syndrome. Mol Cell Pediatr. 2016; 3(1):37. PMC: 5116442. DOI: 10.1186/s40348-016-0065-3. View

5.
Yasui D, Gonzales M, Aflatooni J, Crary F, Hu D, Gavino B . Mice with an isoform-ablating Mecp2 exon 1 mutation recapitulate the neurologic deficits of Rett syndrome. Hum Mol Genet. 2013; 23(9):2447-58. PMC: 3976336. DOI: 10.1093/hmg/ddt640. View